Autor: "Riva, Agostino" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: Clinical Features and Outcomes of Patients With Human Immunodeficiency Virus With COVID-19.
Autorzy :: Gervasoni C; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.; Gestione Ambulatoriale Politerapie (GAP) Outpatient Clinic, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
Meraviglia P; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
Riva A; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
Giacomelli A; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
Oreni L; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
Minisci D; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
Atzori C; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
Ridolfo A; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
Cattaneo D; Gestione Ambulatoriale Politerapie (GAP) Outpatient Clinic, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.; Unit of Clinical Pharmacology, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.; Pokaż więcej
Źródło :: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2020 Nov 19; Vol. 71 (16), pp. 2276-2278.
Typ publikacji :: Journal Article; Observational Study
MeSH Terms :: COVID-19/*complications
HIV Infections/*complications
Adult ; Antiviral Agents/therapeutic use ; COVID-19/drug therapy ; Female ; Hospitalization ; Humans ; Italy ; Male ; Middle Aged ; Prognosis ; Retrospective Studies ; Risk Factors ; SARS-CoV-2
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: Dosing of Dolutegravir in TB/HIV Coinfected Patients on Rifampicin: Twice Is (Always) Better Than Once.
Autorzy :: Cattaneo D; Unit of Clinical Pharmacology, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.; Department of Infectious Diseases, Gestione Ambulatoriale Politerapie (GAP) Outpatient Clinic, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
Riva A; Third Division of Infectious Diseases, Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
Columpsi P; Unit of Infectious Diseases, ASST, Monza University Hospital, Monza, Italy.
Lapadula G; Unit of Infectious Diseases, ASST, Monza University Hospital, Monza, Italy.
Filice C; Infectious Diseases Department, San Matteo Hospital Foundation, University of Pavia, Pavia, Italy.
Gervasoni C; Unit of Clinical Pharmacology, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.; Third Division of Infectious Diseases, Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.; Pokaż więcej
Źródło :: Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2020 Jul 01; Vol. 84 (3), pp. e17-e20.
Typ publikacji :: Letter
MeSH Terms :: HIV Infections/*drug therapy
Heterocyclic Compounds, 3-Ring/*therapeutic use
Oxazines/*therapeutic use
Piperazines/*therapeutic use
Pyridones/*therapeutic use
Rifampin/*therapeutic use
Tuberculosis/*drug therapy
Adult ; Aged ; Coinfection/drug therapy ; Female ; HIV Integrase Inhibitors/therapeutic use ; Humans ; Male ; Middle Aged ; Rifampin/administration & dosage
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: Darunavir does not prevent SARS-CoV-2 infection in HIV patients.
Autorzy :: Riva A; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy; Department of Biomedical and Clinical Sciences 'L. Sacco', University of Milan, Milano, Italy.
Conti F; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy; Department of Biomedical and Clinical Sciences 'L. Sacco', University of Milan, Milano, Italy.
Bernacchia D; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy; Department of Biomedical and Clinical Sciences 'L. Sacco', University of Milan, Milano, Italy.
Pezzati L; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy; Department of Biomedical and Clinical Sciences 'L. Sacco', University of Milan, Milano, Italy.
Sollima S; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy; Department of Biomedical and Clinical Sciences 'L. Sacco', University of Milan, Milano, Italy.
Merli S; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy; Department of Biomedical and Clinical Sciences 'L. Sacco', University of Milan, Milano, Italy.
Siano M; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy; Department of Biomedical and Clinical Sciences 'L. Sacco', University of Milan, Milano, Italy.
Lupo A; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy; Department of Biomedical and Clinical Sciences 'L. Sacco', University of Milan, Milano, Italy.
Rusconi S; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy; Department of Biomedical and Clinical Sciences 'L. Sacco', University of Milan, Milano, Italy.
Cattaneo D; Department of Biomedical and Clinical Sciences 'L. Sacco', University of Milan, Milano, Italy; Unit of Clinical Pharmacology, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy; Gestione Ambulatoriale Politerapie (GAP) Outpatient Clinic, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
Gervasoni C; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy; Department of Biomedical and Clinical Sciences 'L. Sacco', University of Milan, Milano, Italy; Gestione Ambulatoriale Politerapie (GAP) Outpatient Clinic, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy. Electronic address: .; Pokaż więcej
Źródło :: Pharmacological research [Pharmacol Res] 2020 Jul; Vol. 157, pp. 104826. Date of Electronic Publication: 2020 Apr 20.
Typ publikacji :: Letter; Comment
MeSH Terms :: HIV Infections*
Ritonavir*
Betacoronavirus ; COVID-19 ; Coronavirus Infections ; Darunavir ; Humans ; Lopinavir ; Pandemics ; Pneumonia, Viral ; Republic of Korea ; Reverse Transcriptase Polymerase Chain Reaction ; SARS-CoV-2
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Elderly HIV-positive women: A gender-based analysis from the Multicenter Italian "GEPPO" Cohort.
Autorzy :: Focà E; Division of Infectious and Tropical Diseases, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Magro P; Division of Infectious and Tropical Diseases, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Guaraldi G; Infectious Diseases Clinic, Department of Mother, Child and Adult Medicine and Surgical Science, University of Modena and Reggio Emilia, Modena, Italy.
Riva A; Third Division of Infectious Diseases, University of Milan, Ospedale L. Sacco, Milano, Italy.
Cattelan AM; Unit of Infectious Diseases, Department of Internal Medicine, Azienda Ospedaliera-Universitaria di Padova, Padova, Italy.
De Socio GV; Department of Infectious Diseases, Azienda Ospedaliero-Universitaria di Perugia, Perugia, Italy.
Costa C; Unit of Infectious Diseases, Department of Medical Sciences, University of Turin, Turin, Italy.
Piconi S; First Division of Infectious Diseases Unit, University of Milan, Ospedale L. Sacco, Milan, Italy.
Celesia BM; Division of Infectious Diseases, University of Catania, ARNAS Garibaldi, Catania, Italy.
Nozza S; Department of Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy.
Orofino G; Unit of Infectious Diseases, Division A, Ospedale Amedeo di Savoia, Turin, Italy.
Castagna A; Department of Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy.
Di Perri G; Unit of Infectious Diseases, Department of Medical Sciences, University of Turin, Turin, Italy.
Castelli F; Division of Infectious and Tropical Diseases, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Calcagno A; Unit of Infectious Diseases, Department of Medical Sciences, University of Turin, Turin, Italy.; Pokaż więcej
Corporate Authors :: GEPPO (GEriatric Patients living with HIV/AIDS: a Prospective Multidimensional cOhort) Study Group
Źródło :: PloS one [PLoS One] 2019 Oct 17; Vol. 14 (10), pp. e0222225. Date of Electronic Publication: 2019 Oct 17 (Print Publication: 2019).
Typ publikacji :: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :: Bone Diseases/*epidemiology
CD4-Positive T-Lymphocytes/*drug effects
HIV Infections/*epidemiology
HIV-1/*drug effects
Aged ; Aged, 80 and over ; Anti-HIV Agents/administration & dosage ; Bone Diseases/complications ; Bone Diseases/pathology ; Bone Diseases/virology ; CD4-Positive T-Lymphocytes/virology ; Cardiovascular Diseases/complications ; Cardiovascular Diseases/epidemiology ; Cardiovascular Diseases/pathology ; Cardiovascular Diseases/virology ; Cohort Studies ; Drug Therapy, Combination ; Female ; HIV Infections/complications ; HIV Infections/drug therapy ; HIV Infections/virology ; HIV Seropositivity/blood ; HIV Seropositivity/virology ; HIV-1/pathogenicity ; Humans ; Male ; RNA, Viral/genetics ; Sex Characteristics ; Viral Load/drug effects
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 5 5.

Tytuł :: Switch to dolutegravir and unboosted atazanavir in HIV-1 infected patients with undetectable viral load and long exposure to antiretroviral therapy.
Autorzy :: Castagna A; Infectious Diseases Department, IRCCS San Raffaele Scientific Institute & Vita-Salute University.
Rusconi S; Infectious Diseases Unit, DIBIC Luigi Sacco, University of Milan, Milan.
Gulminetti R; Infectious Diseases Unit, Fondazione IRCCS Policlinico San Matteo, Pavia.
Bonora S; Infectious Diseases Unit, Amedeo di Savoia Hospital, University of Turin, Turin.
Mazzola G; Infectious Diseases Unit, Paolo Giaccone/Azienda Ospedaliera Universitaria Policlinico, Palermo.
Quiros-Roldan ME; Infectious Diseases Unit, Spedali Civili General Hospital, Brescia.
De Socio GV; Infectious Diseases Unit, Azienda Ospedaliero-Universitaria di Perugia, Perugia.
Ladisa N; Infectious Diseases Unit, Azienda Universitaria Ospedaliera Consorziale - Policlinico di Bari, Bari.
Carosella S; Infectious Diseases Unit, Amedeo di Savoia Hospital, Turin.
Cattelan A; Infectious Diseases Unit, Azienda Ospedaliera-Universitaria di Padova, Padova.
Di Giambenedetto S; Infectious Diseases Unit, Catholic University of Sacred Heart, Rome.
Mena M; Infectious Diseases Unit, Azienda Ospedaliera di Legnano, ASST Ovest Milanese, Legnano, Italy.
Poli A; Infectious Diseases Department, IRCCS San Raffaele Scientific Institute & Vita-Salute University.
Galli L; Infectious Diseases Department, IRCCS San Raffaele Scientific Institute & Vita-Salute University.
Riva A; Infectious Diseases Unit, DIBIC Luigi Sacco, University of Milan, Milan.; Pokaż więcej
Corporate Authors :: DAU Study Group
Źródło :: AIDS (London, England) [AIDS] 2019 Jun 01; Vol. 33 (7), pp. 1256-1260.
Typ publikacji :: Letter; Research Support, Non-U.S. Gov't
MeSH Terms :: Drug Substitution*
Atazanavir Sulfate/*therapeutic use
HIV Infections/*drug therapy
HIV Integrase Inhibitors/*therapeutic use
Heterocyclic Compounds, 3-Ring/*therapeutic use
Antiretroviral Therapy, Highly Active ; CD4 Lymphocyte Count ; Drug Therapy, Combination ; Female ; HIV-1/drug effects ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Oxazines ; Piperazines ; Pyridones ; RNA, Viral/blood ; Treatment Outcome ; Viral Load
: Raport

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: Choroidal Thickness in Patients Diagnosed with Human Immunodeficiency Virus Infection: Results from Two Populations of Different Ethnicities: Response to Chay et al.'s Letter.
Autorzy :: Agarwal A; a Department of Ophthalmology, Advanced Eye Center , Post Graduate Institute of Medical Education and Research (PGIMER) , Chandigarh , India.
Invernizzi A; b Eye Clinic - Department of Biomedical and Clinical Science 'Luigi Sacco' , Luigi Sacco Hospital - University of Milan , Milan , Italy.; c Save Sight Institute , University of Sydney , Sydney , Australia.
Jain S; a Department of Ophthalmology, Advanced Eye Center , Post Graduate Institute of Medical Education and Research (PGIMER) , Chandigarh , India.
Acquistapace A; b Eye Clinic - Department of Biomedical and Clinical Science 'Luigi Sacco' , Luigi Sacco Hospital - University of Milan , Milan , Italy.
Riva A; d Department of Clinical Sciences, Luigi Sacco Hospital, Section of Infectious and Tropical Diseases , University of Milan , Milan , Italy.
Sharma A; e Department of Internal Medicine , Post Graduate Institute of Medical Education and Research (PGIMER) , Chandigarh , India.
Gupta V; a Department of Ophthalmology, Advanced Eye Center , Post Graduate Institute of Medical Education and Research (PGIMER) , Chandigarh , India.
Singh R; a Department of Ophthalmology, Advanced Eye Center , Post Graduate Institute of Medical Education and Research (PGIMER) , Chandigarh , India.; Pokaż więcej
Źródło :: Ocular immunology and inflammation [Ocul Immunol Inflamm] 2019; Vol. 27 (4), pp. 569-570. Date of Electronic Publication: 2018 Aug 24.
Typ publikacji :: Journal Article; Comment
MeSH Terms :: HIV Infections/*virology
Choroid ; Ethnic Groups ; HIV ; Humans
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 7 7.

Tytuł :: Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy.
Autorzy :: Giacomelli A; Infectious Diseases Unit, DIBIC Luigi Sacco - University of Milan, Via G.B. Grassi, 74, 20157, Milan, Italy. .
Riva A; Infectious Diseases Unit, DIBIC Luigi Sacco - University of Milan, Via G.B. Grassi, 74, 20157, Milan, Italy.
Falvella FS; ASST Fatebenefratelli-Sacco, Clinical Pharmacology Unit, Milan, Italy.
Oreni ML; Infectious Diseases Unit, DIBIC Luigi Sacco - University of Milan, Via G.B. Grassi, 74, 20157, Milan, Italy.
Cattaneo D; ASST Fatebenefratelli-Sacco, Clinical Pharmacology Unit, Milan, Italy.
Cheli S; ASST Fatebenefratelli-Sacco, Clinical Pharmacology Unit, Milan, Italy.
Renisi G; Infectious Diseases Unit, DIBIC Luigi Sacco - University of Milan, Via G.B. Grassi, 74, 20157, Milan, Italy.
Di Cristo V; Infectious Diseases Unit, DIBIC Luigi Sacco - University of Milan, Via G.B. Grassi, 74, 20157, Milan, Italy.
Lupo A; Infectious Diseases Unit, DIBIC Luigi Sacco - University of Milan, Via G.B. Grassi, 74, 20157, Milan, Italy.
Clementi E; ASST Fatebenefratelli-Sacco, Clinical Pharmacology Unit, Milan, Italy.; E. Medea Scientific Institute, Bosisio Parini, Italy.
Rusconi S; Infectious Diseases Unit, DIBIC Luigi Sacco - University of Milan, Via G.B. Grassi, 74, 20157, Milan, Italy.
Galli M; Infectious Diseases Unit, DIBIC Luigi Sacco - University of Milan, Via G.B. Grassi, 74, 20157, Milan, Italy.
Ridolfo AL; Infectious Diseases Unit, DIBIC Luigi Sacco - University of Milan, Via G.B. Grassi, 74, 20157, Milan, Italy.; Pokaż więcej
Źródło :: BMC infectious diseases [BMC Infect Dis] 2018 Nov 12; Vol. 18 (1), pp. 556. Date of Electronic Publication: 2018 Nov 12.
Typ publikacji :: Journal Article
MeSH Terms :: Chemical and Drug Induced Liver Injury*/epidemiology
Chemical and Drug Induced Liver Injury*/genetics
Anti-HIV Agents/*adverse effects
HIV Infections/*drug therapy
Nevirapine/*adverse effects
Adult ; Anti-HIV Agents/administration & dosage ; Anti-Retroviral Agents/administration & dosage ; Anti-Retroviral Agents/adverse effects ; Drug Therapy, Combination/adverse effects ; Female ; Genetic Predisposition to Disease ; HIV ; HIV Infections/complications ; HIV Infections/epidemiology ; HIV Infections/genetics ; Humans ; Male ; Middle Aged ; Nevirapine/administration & dosage ; Retrospective Studies ; Risk Factors ; Severity of Illness Index
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 8 8.

Tytuł :: CD32 Lymph Node CD4 T Cells Support Persistent HIV-1 Transcription in Treated Aviremic Individuals.
Autorzy :: Noto A; Service of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Procopio FA; Service of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Banga R; Service of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Suffiotti M; Service of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Corpataux JM; Service of Vascular Surgery, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Cavassini M; Service of Infectious Diseases, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Riva A; Infectious Disease Division, Luigi Sacco University Hospital, Milan, Italy.
Fenwick C; Service of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Gottardo R; Vaccine Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Perreau M; Service of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Pantaleo G; Service of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland .; Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.; Pokaż więcej
Źródło :: Journal of virology [J Virol] 2018 Sep 26; Vol. 92 (20). Date of Electronic Publication: 2018 Sep 26 (Print Publication: 2018).
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Transcription, Genetic*
CD4-Positive T-Lymphocytes/*virology
HIV Infections/*pathology
HIV-1/*growth & development
Lymph Nodes/*pathology
T-Lymphocyte Subsets/*virology
Adult ; Anti-Retroviral Agents/therapeutic use ; CD4-Positive T-Lymphocytes/chemistry ; DNA, Viral/analysis ; Female ; HIV Infections/drug therapy ; Humans ; Male ; Middle Aged ; Programmed Cell Death 1 Receptor/analysis ; RNA, Viral/analysis ; Receptors, IgG/analysis ; T-Lymphocyte Subsets/chemistry ; Young Adult
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Effects of ritonavir and cobicistat on dolutegravir exposure: when the booster can make the difference.
Autorzy :: Gervasoni C; Department of Infectious Diseases, L. Sacco University Hospital, Milan, Italy.
Riva A; Department of Infectious Diseases, L. Sacco University Hospital, Milan, Italy.
Cozzi V; Unit of Clinical Pharmacology, L. Sacco University Hospital, Milan, Italy.
Capetti A; Department of Infectious Diseases, L. Sacco University Hospital, Milan, Italy.
Rizzardini G; Department of Infectious Diseases, L. Sacco University Hospital, Milan, Italy.
Clementi E; Clinical Pharmacology Unit, Department Biomedical and Clinical Sciences, CNR Institute of Neuroscience, L. Sacco University Hospital, Università di Milano, Milan, Italy.; Scientific Institute IRCCS E.Medea, Bosisio Parini 23842, Italy.
Cattaneo D; Unit of Clinical Pharmacology, L. Sacco University Hospital, Milan, Italy.; Pokaż więcej
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2017 Jun 01; Vol. 72 (6), pp. 1842-1844.
Typ publikacji :: Letter
MeSH Terms :: Anti-HIV Agents/*pharmacokinetics
Cobicistat/*pharmacokinetics
Cytochrome P-450 CYP3A Inhibitors/*pharmacokinetics
Darunavir/*pharmacokinetics
HIV Infections/*drug therapy
HIV Integrase Inhibitors/*pharmacokinetics
HIV Protease Inhibitors/*pharmacokinetics
Heterocyclic Compounds, 3-Ring/*pharmacokinetics
Ritonavir/*pharmacokinetics
Anti-HIV Agents/therapeutic use ; Cobicistat/therapeutic use ; Cytochrome P-450 CYP3A Inhibitors/therapeutic use ; Darunavir/therapeutic use ; Drug Therapy, Combination ; Female ; HIV Integrase Inhibitors/therapeutic use ; HIV Protease Inhibitors/therapeutic use ; HIV-1/drug effects ; Heterocyclic Compounds, 3-Ring/therapeutic use ; Humans ; Male ; Middle Aged ; Oxazines ; Piperazines ; Pyridones ; Ritonavir/therapeutic use
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: Activating Killer Immunoglobulin Receptors and HLA-C: a successful combination providing HIV-1 control.
Autorzy :: Malnati MS; Unit of Human Virology, Division of Immunology, transplantation and Infectious Diseases IRCCS Ospedale San Raffaele, Milan, Italy.
Ugolotti E; IRCCS Giannina Gaslini, Genoa, Italy.
Monti MC; Department of Public Health Unit of biostatistics and clinical epidemiology University of Pavia, Pavia Italy.
Battista D; Unit of Human Virology, Division of Immunology, transplantation and Infectious Diseases IRCCS Ospedale San Raffaele, Milan, Italy.
Vanni I; IRCCS Giannina Gaslini, Genoa, Italy.
Bordo D; IRCCS AOU San Martino-IST, Genoa, Italy.
Sironi F; Unit of Human Virology, Division of Immunology, transplantation and Infectious Diseases IRCCS Ospedale San Raffaele, Milan, Italy.
Larghero P; IRCCS Giannina Gaslini, Genoa, Italy.
Marco ED; IRCCS Giannina Gaslini, Genoa, Italy.
Biswas P; Unit of Human Virology, Division of Immunology, transplantation and Infectious Diseases IRCCS Ospedale San Raffaele, Milan, Italy.
Poli G; Vita-Salute San Raffaele University, School of Medicine, Milan, Italy.
Vicenzi E; Unit of Viral Pathogens and Biosafety, Division of Immunology, Transplantation and Infectious Diseases, IRCCS Ospedale San Raffaele, Milan, Italy.
Riva A; Department of Clinical Sciences Chair of Infectious Diseases and Tropical Medicine University of Milan,'L. Sacco' Hospital, Milan, Italy.
Tarkowski M; Department of Clinical Sciences Chair of Infectious Diseases and Tropical Medicine University of Milan,'L. Sacco' Hospital, Milan, Italy.
Tambussi G; Department of Infectious Diseases, IRCCS Ospedale San Raffaele, Milan, Italy.
Nozza S; Department of Infectious Diseases, IRCCS Ospedale San Raffaele, Milan, Italy.
Tripodi G; IRCCS Giannina Gaslini, Genoa, Italy.
Marras F; IRCCS Giannina Gaslini, Genoa, Italy.
De Maria A; IRCCS AOU San Martino-IST, Genoa, Italy.; Department of Health Science, DISSAL and Center for excellence in Biomedical Research CEBR University of Genoa, Genoa, Italy.
Pistorio A; IRCCS Giannina Gaslini, Genoa, Italy.
Biassoni R; IRCCS Giannina Gaslini, Genoa, Italy.; Pokaż więcej
Źródło :: Scientific reports [Sci Rep] 2017 Feb 13; Vol. 7, pp. 42470. Date of Electronic Publication: 2017 Feb 13.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: HIV Infections/*immunology
HIV Infections/*metabolism
HIV Infections/*virology
HIV-1/*immunology
HLA-C Antigens/*immunology
Host-Pathogen Interactions/*immunology
Receptors, KIR/*agonists
Alleles ; CD4-Positive T-Lymphocytes/immunology ; CD4-Positive T-Lymphocytes/metabolism ; CD4-Positive T-Lymphocytes/virology ; Chromosomes, Human, Pair 19 ; Chromosomes, Human, Pair 6 ; Disease Progression ; Genetic Predisposition to Disease ; Genotype ; HIV Infections/genetics ; HLA-C Antigens/genetics ; Histocompatibility Antigens Class I/genetics ; Histocompatibility Antigens Class I/immunology ; Host-Pathogen Interactions/genetics ; Humans ; Odds Ratio ; Polymorphism, Genetic ; Receptors, KIR/genetics ; Receptors, KIR/metabolism
: Czasopismo naukowe

Szczegóły Pełny tekst

Skocz do pozycji: 11 11.

Tytuł :: Dolutegravir plasma concentrations according to companion antiretroviral drug: unwanted drug interaction or desirable boosting effect?
Autorzy :: Cattaneo D; Unit of Clinical Pharmacology, L. Sacco University Hospital, Milan, Italy.
Minisci D; Department of Infectious Diseases, L. Sacco University Hospital, Milan, Italy.
Cozzi V; Unit of Clinical Pharmacology, L. Sacco University Hospital, Milan, Italy.
Riva A; Department of Infectious Diseases, L. Sacco University Hospital, Milan, Italy.
Meraviglia P; Department of Infectious Diseases, L. Sacco University Hospital, Milan, Italy.
Clementi E; Clinical Pharmacology Unit, CNR Institute of Neuroscience, Department of Biomedical and Clinical Sciences, L. Sacco University Hospital, Università di Milano, Milan, Italy.; Scientific Institute IRCCS E. Medea, Parini, Italy.
Galli M; Department of Infectious Diseases, L. Sacco University Hospital, Milan, Italy.
Gervasoni C; Department of Infectious Diseases, L. Sacco University Hospital, Milan, Italy.; Pokaż więcej
Źródło :: Antiviral therapy [Antivir Ther] 2017; Vol. 22 (4), pp. 353-356. Date of Electronic Publication: 2016 Dec 23.
Typ publikacji :: Journal Article
MeSH Terms :: Anti-HIV Agents/*blood
Atazanavir Sulfate/*blood
Darunavir/*blood
Dideoxynucleosides/*blood
HIV Infections/*drug therapy
HIV Integrase Inhibitors/*blood
Heterocyclic Compounds, 3-Ring/*blood
Lamivudine/*blood
Rilpivirine/*blood
Anti-HIV Agents/pharmacokinetics ; Anti-HIV Agents/pharmacology ; Atazanavir Sulfate/pharmacokinetics ; Atazanavir Sulfate/pharmacology ; Biological Availability ; CD4 Lymphocyte Count ; Darunavir/pharmacokinetics ; Darunavir/pharmacology ; Dideoxynucleosides/pharmacokinetics ; Dideoxynucleosides/pharmacology ; Drug Administration Schedule ; Drug Combinations ; Drug Dosage Calculations ; Drug Interactions ; Female ; HIV Infections/blood ; HIV Infections/immunology ; HIV Infections/virology ; HIV Integrase Inhibitors/pharmacokinetics ; HIV Integrase Inhibitors/pharmacology ; HIV-1/drug effects ; HIV-1/physiology ; Heterocyclic Compounds, 3-Ring/pharmacokinetics ; Heterocyclic Compounds, 3-Ring/pharmacology ; Humans ; Lamivudine/pharmacokinetics ; Lamivudine/pharmacology ; Male ; Middle Aged ; Oxazines ; Piperazines ; Pyridones ; Retrospective Studies ; Rilpivirine/pharmacokinetics ; Rilpivirine/pharmacology ; Viral Load/drug effects
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Elvitegravir/cobicistat-associated toxic optical neuropathy in an HIV-infected patient: a call for caution?
Autorzy :: Riva A; 3rd Division of Infectious Diseases, Luigi Sacco University Hospital, Milan, Italy.
Invernizzi A; Eye Clinic, Department of Biomedical and Clinical Science, Luigi Sacco University Hospital, Milan, Italy.
Resnati C; 3rd Division of Infectious Diseases, Luigi Sacco University Hospital, Milan, Italy.
Micheli V; Clinical Microbiology, Virology and Diagnosis of Bioemergency, Luigi Sacco University Hospital, Milan, Italy.
Cattaneo D; Unit of Clinical Pharmacology, Luigi Sacco University Hospital, Milan, Italy.
Gervasoni C; 3rd Division of Infectious Diseases, Luigi Sacco University Hospital, Milan, Italy.; Pokaż więcej
Źródło :: Antiviral therapy [Antivir Ther] 2017; Vol. 22 (5), pp. 453-455. Date of Electronic Publication: 2016 Jun 22.
Typ publikacji :: Case Reports; Journal Article
MeSH Terms :: Cobicistat/*adverse effects
HIV Infections/*complications
Optic Nerve Diseases/*diagnosis
Optic Nerve Diseases/*etiology
Quinolones/*adverse effects
Antiretroviral Therapy, Highly Active/adverse effects ; Antiretroviral Therapy, Highly Active/methods ; CD4 Lymphocyte Count ; Cobicistat/therapeutic use ; HIV Infections/diagnosis ; HIV Infections/drug therapy ; HIV-1 ; Humans ; Male ; Middle Aged ; Quinolones/therapeutic use ; Viral Load
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Severe Hyperbilirubinemia in an HIV-HCV-Coinfected Patient Starting the 3D Regimen That Resolved After TDM-Guided Atazanavir Dose Reduction.
Autorzy :: Cattaneo D; Unit of Clinical Pharmacology; †Department of Infectious Diseases; ‡Clinical Pharmacology Unit, CNR Institute of Neuroscience, Department of Biomedical and Clinical Sciences, L. Sacco University Hospital, Università di Milano, Milan; and §Scientific Institute IRCCS E. Medea, Bosisio Parini, Italy.
Riva A
Clementi E
Milazzo L
Gervasoni C; Pokaż więcej
Źródło :: Therapeutic drug monitoring [Ther Drug Monit] 2016 Jun; Vol. 38 (3), pp. 285-7.
Typ publikacji :: Case Reports; Journal Article
MeSH Terms :: Antiviral Agents/*administration & dosage
Atazanavir Sulfate/*adverse effects
HIV Infections/*drug therapy
Hepatitis C/*drug therapy
Hyperbilirubinemia/*chemically induced
Anilides/administration & dosage ; Antiviral Agents/adverse effects ; Atazanavir Sulfate/administration & dosage ; Atazanavir Sulfate/pharmacokinetics ; Carbamates/administration & dosage ; Coinfection ; Dose-Response Relationship, Drug ; Drug Interactions ; Drug Monitoring/methods ; Drug Therapy, Combination ; Female ; Follow-Up Studies ; HIV Infections/complications ; HIV Protease Inhibitors/administration & dosage ; HIV Protease Inhibitors/adverse effects ; HIV Protease Inhibitors/pharmacokinetics ; Hepatitis C/complications ; Humans ; Macrocyclic Compounds/administration & dosage ; Middle Aged ; Ritonavir/administration & dosage ; Sulfonamides/administration & dosage ; Uracil/administration & dosage ; Uracil/analogs & derivatives
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: Metabolic and kidney disorders correlate with high atazanavir concentrations in HIV-infected patients: is it time to revise atazanavir dosages?
Autorzy :: Gervasoni C; Department of Infectious Disease, L. Sacco University Hospital, Milan, Italy.
Meraviglia P; Department of Infectious Disease, L. Sacco University Hospital, Milan, Italy.
Minisci D; Department of Infectious Disease, L. Sacco University Hospital, Milan, Italy.
Ferraris L; Department of Infectious Disease, L. Sacco University Hospital, Milan, Italy.
Riva A; Department of Infectious Disease, L. Sacco University Hospital, Milan, Italy.
Landonio S; Department of Infectious Disease, L. Sacco University Hospital, Milan, Italy.
Cozzi V; Unit of Clinical Pharmacology, L. Sacco University Hospital, Milan, Italy.
Charbe N; Unit of Clinical Pharmacology, L. Sacco University Hospital, Milan, Italy.
Molinari L; Department of Infectious Disease, L. Sacco University Hospital, Milan, Italy.
Rizzardini G; Department of Infectious Disease, L. Sacco University Hospital, Milan, Italy; School of Clinical Medicine, Faculty of Health Science, University of the Witwatersrand, Johannesburg, South Africa.
Clementi E; Clinical Pharmacology Unit, Consiglio Nazionale delle Ricerche Institute of Neuroscience, Department of Biomedical and Clinical Sciences, L. Sacco University Hospital, Università degli Studi di Milano, Milan, Italy; E. Medea Scientific Institute, Bosisio Parini, Italy.
Galli M; Department of Infectious Disease, L. Sacco University Hospital, Milan, Italy.
Cattaneo D; Unit of Clinical Pharmacology, L. Sacco University Hospital, Milan, Italy.; Pokaż więcej
Źródło :: PloS one [PLoS One] 2015 Apr 15; Vol. 10 (4), pp. e0123670. Date of Electronic Publication: 2015 Apr 15 (Print Publication: 2015).
Typ publikacji :: Journal Article
MeSH Terms :: Atazanavir Sulfate/*blood
Dyslipidemias/*diagnosis
HIV Infections/*drug therapy
HIV Protease Inhibitors/*blood
Hyperbilirubinemia/*diagnosis
Nephrolithiasis/*diagnosis
Adult ; Antiretroviral Therapy, Highly Active ; Atazanavir Sulfate/administration & dosage ; Atazanavir Sulfate/adverse effects ; Atazanavir Sulfate/pharmacokinetics ; Drug Administration Schedule ; Drug Dosage Calculations ; Drug Monitoring ; Dyslipidemias/blood ; Dyslipidemias/chemically induced ; Dyslipidemias/physiopathology ; Female ; HIV Infections/virology ; HIV Protease Inhibitors/administration & dosage ; HIV Protease Inhibitors/adverse effects ; HIV Protease Inhibitors/pharmacokinetics ; HIV-1/drug effects ; HIV-1/physiology ; Humans ; Hyperbilirubinemia/blood ; Hyperbilirubinemia/chemically induced ; Hyperbilirubinemia/physiopathology ; Male ; Middle Aged ; Nephrolithiasis/blood ; Nephrolithiasis/chemically induced ; Nephrolithiasis/physiopathology ; Ritonavir/adverse effects ; Viral Load/drug effects
: Czasopismo naukowe

Szczegóły Pełny tekst

Skocz do pozycji: 15 15.

Tytuł :: Potential association between rosuvastatin use and high atazanavir trough concentrations in ritonavir-treated HIV-infected patients.
Autorzy :: Gervasoni C; Department of Infectious Diseases, Luigi Sacco University Hospital, Milan, Italy. .
Riva A
Rizzardini G
Clementi E
Galli M
Cattaneo D; Pokaż więcej
Źródło :: Antiviral therapy [Antivir Ther] 2015; Vol. 20 (4), pp. 449-51. Date of Electronic Publication: 2014 Oct 03.
Typ publikacji :: Journal Article
MeSH Terms :: Atazanavir Sulfate/*pharmacokinetics
HIV Infections/*drug therapy
HIV Protease Inhibitors/*pharmacokinetics
Hydroxymethylglutaryl-CoA Reductase Inhibitors/*pharmacokinetics
Ritonavir/*pharmacokinetics
Rosuvastatin Calcium/*pharmacokinetics
Adult ; Age Factors ; Atazanavir Sulfate/blood ; Atazanavir Sulfate/pharmacology ; Body Weight ; Drug Administration Schedule ; Drug Interactions ; Drug Monitoring ; Female ; HIV Infections/virology ; HIV Protease Inhibitors/blood ; HIV Protease Inhibitors/pharmacology ; HIV-1/drug effects ; HIV-1/enzymology ; HIV-1/growth & development ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/blood ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology ; Male ; Middle Aged ; Retrospective Studies ; Ritonavir/blood ; Ritonavir/pharmacology ; Rosuvastatin Calcium/blood ; Rosuvastatin Calcium/pharmacology ; Sex Factors ; Viral Load/drug effects
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: Low body weight in females is a risk factor for increased tenofovir exposure and drug-related adverse events.
Autorzy :: Gervasoni C; Department of Infectious Disease, L. Sacco University Hospital, Milan, Italy.
Meraviglia P
Landonio S
Baldelli S
Fucile S
Castagnoli L
Clementi E
Riva A
Galli M
Rizzardini G
Cattaneo D; Pokaż więcej
Źródło :: PloS one [PLoS One] 2013 Dec 02; Vol. 8 (12), pp. e80242. Date of Electronic Publication: 2013 Dec 02 (Print Publication: 2013).
Typ publikacji :: Clinical Trial; Journal Article
MeSH Terms :: Anti-HIV Agents*/administration & dosage
Anti-HIV Agents*/adverse effects
Anti-HIV Agents*/pharmacokinetics
Organophosphonates*/administration & dosage
Organophosphonates*/adverse effects
Organophosphonates*/pharmacokinetics
Adenine/*analogs & derivatives
Body Weight/*drug effects
Bone Resorption/*chemically induced
HIV Infections/*drug therapy
Adenine/administration & dosage ; Adenine/adverse effects ; Adenine/pharmacokinetics ; Adult ; Bone Resorption/metabolism ; Bone Resorption/physiopathology ; Female ; HIV Infections/metabolism ; HIV Infections/physiopathology ; Humans ; Middle Aged ; Risk Factors ; Tenofovir
: Czasopismo naukowe

Szczegóły Pełny tekst

Skocz do pozycji: 17 17.

Tytuł :: Novel genetic association of TNF-α-238 and PDCD1-7209 polymorphisms with long-term non-progressive HIV-1 infection.
Autorzy :: Nasi M; Department of Surgery, Medicine, Dentistry and Morphological Sciences, University of Modena and Reggio Emilia, Via Campi 287, 41125 Modena, Italy. Electronic address: .
Riva A
Borghi V
D'Amico R
Del Giovane C
Casoli C
Galli M
Vicenzi E
Gibellini L
De Biasi S
Clerici M
Mussini C
Cossarizza A
Pinti M; Pokaż więcej
Źródło :: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2013 Oct; Vol. 17 (10), pp. e845-50. Date of Electronic Publication: 2013 Feb 10.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: HIV Infections/*genetics
HIV-1/*immunology
Programmed Cell Death 1 Receptor/*genetics
Tumor Necrosis Factor-alpha/*genetics
Adaptive Immunity/genetics ; Adult ; Aged ; Disease Progression ; Female ; Gene Frequency ; Genetic Association Studies ; Genetic Predisposition to Disease ; HIV Infections/immunology ; Host-Pathogen Interactions/genetics ; Humans ; Major Histocompatibility Complex ; Male ; Middle Aged ; Polymorphism, Single Nucleotide ; RNA, Long Noncoding ; RNA, Untranslated
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: Identification of TRIM22 single nucleotide polymorphisms associated with loss of inhibition of HIV-1 transcription and advanced HIV-1 disease.
Autorzy :: Ghezzi S; aViral Pathogens and Biosafety Unit, Division of Immunology, Transplantation and Infectious Diseases bDepartment of Infectious Diseases cDivision of Genetics and Cell Biology, San Raffaele Scientific Institute dUniversity of Milan eGEMIB srl, Parma fAIDS Immunopathogenesis Unit, Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute gUniversità Vita-Salute San Raffaele, School of Medicine, Milan, Italy.
Galli L
Kajaste-Rudnitski A
Turrini F
Marelli S
Toniolo D
Casoli C
Riva A
Poli G
Castagna A
Vicenzi E; Pokaż więcej
Źródło :: AIDS (London, England) [AIDS] 2013 Sep 24; Vol. 27 (15), pp. 2335-44.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: HIV Infections/*genetics
HIV-1/*genetics
Polymorphism, Single Nucleotide/*genetics
Repressor Proteins/*genetics
Adult ; Disease Progression ; Female ; Haplotypes ; Humans ; Male ; Middle Aged ; Minor Histocompatibility Antigens ; Transcription, Genetic ; Tripartite Motif Proteins ; Virus Replication
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: Systemic lupus erythematosus and HIV infection: a whimsical relationship. Reports of two cases and review of the literature.
Autorzy :: Carugati M; Department of Clinical Science, University of Milan, Luigi Sacco Hospital, Via G.B. Grassi 74, 20157, Milan, Italy. />Franzetti M
Torre A
Giorgi R
Genderini A
Strambio de Castilla F
Gervasoni C
Riva A; Pokaż więcej
Źródło :: Clinical rheumatology [Clin Rheumatol] 2013 Sep; Vol. 32 (9), pp. 1399-405. Date of Electronic Publication: 2013 May 07.
Typ publikacji :: Case Reports; Journal Article; Review
MeSH Terms :: HIV Infections/*complications
Lupus Erythematosus, Systemic/*complications
Adult ; Africa ; Anti-Retroviral Agents/therapeutic use ; CD4-Positive T-Lymphocytes/immunology ; Comorbidity ; Female ; HIV Infections/immunology ; HIV Infections/physiopathology ; Humans ; Lupus Erythematosus, Systemic/immunology ; Lupus Erythematosus, Systemic/physiopathology ; Remission Induction ; Retrospective Studies ; Risk Factors
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: Is chewed raltegravir an option to care for HIV-infected patients with active tuberculosis?
Autorzy :: Gervasoni C
Riva A
Impagnatiello C
Galli M
Cattaneo D; Pokaż więcej
Źródło :: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2013 Aug; Vol. 57 (3), pp. 480-1. Date of Electronic Publication: 2013 Apr 24.
Typ publikacji :: Letter
MeSH Terms :: Drug Interactions*
Anti-HIV Agents/*administration & dosage
Antitubercular Agents/*administration & dosage
HIV Infections/*drug therapy
Pyrrolidinones/*administration & dosage
Rifampin/*administration & dosage
Tuberculosis/*drug therapy
Administration, Oral ; Anti-HIV Agents/pharmacokinetics ; Antitubercular Agents/pharmacokinetics ; Coinfection/drug therapy ; HIV Infections/complications ; Humans ; Pyrrolidinones/pharmacokinetics ; Raltegravir Potassium ; Rifampin/pharmacokinetics ; Tuberculosis/complications
: Opinia redakcyjna

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Riva, Agostino"" wg kryterium: Autor

Aktywne filtry:

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język